Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 5/20 | 0.30 |
| ▸ | ESR2 | Q92731 | 5/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14879909 | 0.69 | ESR2 (0.31) | ESR2 | |
| SCHEMBL901128 | 0.65 | ESR2 (0.31) | ESR2 | |
| SCHEMBL180087 | 0.63 | — | — | |
| SCHEMBL29652246 | 0.62 | CA1 (0.30) | — | |
| SCHEMBL1123913 | 0.62 | KDM1A (0.31) | — | |
| SCHEMBL1460611 | 0.62 | — | — | |
| SCHEMBL6206710 | 0.61 | GAA (0.35) | — | |
| SCHEMBL6206711 | 0.61 | GAA (0.35) | — | |
| SCHEMBL6206708 | 0.61 | GAA (0.35) | — | |
| SCHEMBL28605156 | 0.61 | NOS1 (0.38) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106010302-B | Adhesive composition, adhesive sheet, and optical film with adhesive layer | 琳得科株式会社 | 2024-02-13 | — | — | CN | disclosed |
| CN-117486665-A | Method for co-producing norbornene and dimethylbridge octahydronaphthalene through microchannel reactor | 浙江大学 | 2024-02-02 | — | — | CN | disclosed |
| CN-117486665-A | Method for co-producing norbornene and dimethylbridge octahydronaphthalene through microchannel reactor | 浙江大学 | 2024-02-02 | — | — | CN | disclosed |
| EP-2621995-B1 | ADVANCED EPOXY RESIN COMPOSITIONS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2016-03-23 | — | — | EP | disclosed |
| US-9284434-B2 | Epoxy resin compositions | BLUE CUBE IP LLC (US) | 2016-03-15 | — | — | US | disclosed |
| EP-2621990-B1 | THERMOSETTABLE COMPOSITIONS AND THERMOSETS THEREFROM | BLUE CUBE IP LLC (US) | 2016-02-24 | — | — | EP | disclosed |
| US-9068039-B2 | Thermosettable compositions and thermosets therefrom | DOW GLOBAL TECHNOLOGIES LLC (US) | 2015-06-30 | — | — | US | disclosed |
| US-20150152285-A1 | ADVANCED EPOXY RESIN COMPOSITIONS | BLUE CUBE IP LLC | 2015-06-04 | — | — | US | disclosed |
| US-20140194554-A1 | EPOXY RESIN COMPOSITIONS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2014-07-10 | — | — | US | disclosed |
| US-20130302336-A1 | DISULFIDE STABILIZED DVD-IG MOLECULES | UCB PHARMA S.A. (BE) | 2013-11-14 | — | — | US | disclosed |
| US-20130237642-A1 | THERMOSETTABLE COMPOSITIONS AND THERMOSETS THEREFROM | DOW GLOBAL TECHNOLOGIES LLC (US) | 2013-09-12 | — | — | US | disclosed |
| EP-2621994-A1 | EPOXY RESIN COMPOSITIONS | Dow Global Technologies LLC (US) | 2013-08-07 | — | — | EP | disclosed |
| EP-2621995-A1 | ADVANCED EPOXY RESIN COMPOSITIONS | Dow Global Technologies LLC (US) | 2013-08-07 | — | — | EP | disclosed |
| EP-2621990-A2 | THERMOSETTABLE COMPOSITIONS AND THERMOSETS THEREFROM | Dow Global Technologies LLC (US) | 2013-08-07 | — | — | EP | disclosed |
| US-20130178591-A1 | ADVANCED POLY EPOXY ESTER RESIN COMPOSITIONS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2013-07-11 | — | — | US | disclosed |
| US-20130178590-A1 | ADVANCED EPOXY RESIN COMPOSITIONS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2013-07-11 | — | — | US | disclosed |
| WO-2012047420-A2 | THERMOSETTABLE COMPOSITIONS AND THERMOSETS THEREFROM | DOW GLOBAL TECHNOLOGIES LLC (US) | 2012-04-12 | — | — | WO | disclosed |
| WO-2012044458-A1 | ADVANCED EPOXY RESIN COMPOSITIONS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2012-04-05 | — | — | WO | disclosed |
| WO-2012044443-A1 | EPOXY RESIN COMPOSITIONS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2012-04-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130302336-A1 | DISULFIDE STABILIZED DVD-IG MOLECULES | EED, DRD2, PSMD14 | ESR1 645/4885ESR2 600/4885CYP3A4 2273/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.